Not Yet RecruitingNot Applicable

What is the Role of Triglyceride-glucose Index as a Predictive Marker for Insulin Resistance in Pre Diabetic Chronic Kidney Disease Patients?

60 participantsStarted 2026-01-01

Plain-language summary

The aim of this study is to evaluate the role of the triglyceride-glucose (TyG) index as a predictive marker for insulin resistance in pre-diabetic patients with chronic kidney disease (CKD), and to investigate its potential utility as a simple, non-invasive alternative to traditional insulin resistance assessment methods.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged ≥18 years Patients with medical history free from renal dysfunction Patients with renal dysfunction (CKD stages 2\_5 based on KDIGO guidelines) No previous diagnosis of diabetes mellitus Provided informed consent Exclusion Criteria: * Known type 1 or type 2 diabetes mellitus Acute kidney injury Use of steroids or medications that affect glucose and lipid metabolism Pregnancy Active infections Malignancy

What they're measuring

Diagnostic performance of TyG index

Timeframe: 2 years

Trial details

NCT IDNCT07279922

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-01-01

View on ClinicalTrials.gov More Chronic Kidney Disease trials